MORGAN STANLEY PLC/CALL/BECTON DICKINSON AND CO./270/0.1/21.03.25 Stock

Warrant

DE000MG0Y1K5

Market Closed - Bid/Ask 02:43:47 2024-06-24 pm EDT After market 03:09:54 pm
0.74 EUR -9.76% Intraday chart for MORGAN STANLEY PLC/CALL/BECTON DICKINSON AND CO./270/0.1/21.03.25 0.79 +6.76%
Current month+46.43%
1 month+12.33%
Date Price Change
24-06-24 0.74 -9.76%
24-06-21 0.82 0.00%
24-06-20 0.82 +22.39%
24-06-19 0.67 -4.29%
24-06-18 0.7 -9.09%

Delayed Quote Börse Stuttgart

Last update June 24, 2024 at 02:43 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MG0Y1K
ISINDE000MG0Y1K5
Date issued 2024-03-27
Strike 270 $
Maturity 2025-03-21 (270 Days)
Parity 10 : 1
Emission price 1.11
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.46
Lowest since issue 0.43
Spread 0.12
Spread %13.95%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
238.3 USD
Average target price
279.2 USD
Spread / Average Target
+17.16%
Consensus